Lymphopenia described in COVID-19, on the other hand, seems to be related to the virus’s ability to infect T cells depending on angiotensin-converting enzyme 2 (ACE2) receptors and CD147-spike protein [28]. The gene discussed is ACE2; the disease is lymphopenia.